Amlodipine Besylate And Atorvastatin Calcium
Pricing Report NDC 59762-6732-1

Latest NADAC: $1.72094 per EA · Effective Jul 19, 2023 · Est. package price $51.63 (30 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Amlodipine Besylate And Atorvastatin Calcium (NDC 59762-6732-1) is $1.72094 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 19, 2023.

As a provided by Mylan Pharmaceuticals Inc., this medication is distributed in a 30 TABLET, FILM COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.72094
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jul 19, 2023
Billable Units
30 EA
Estimated Package Price
$51.63
Data Status
As of Aug 02, 2023
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
59762-6732-1
Description
30 TABLET, FILM COATED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jun 2014, the NADAC wholesale price for (NDC ) has moved within a range of $0.98522 to $6.63410 per EA. Over this 9 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.9852 - $6.6341
Market Volatility
573.36% Variance
Latest Trend
30.75%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jul 19, 2023 $1.72094 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 21, 2023 $2.48528 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 19, 2023 $1.65879 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 19, 2023 $1.65879 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Feb 22, 2023 $0.98522 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 22, 2023 $0.98522 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Dec 21, 2022 $1.31943 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 21, 2022 $1.31943 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Nov 23, 2022 $2.42421 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 17, 2022 $1.59133 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 17, 2022 $1.59133 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jul 20, 2022 $2.57745 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026